These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29345192)

  • 1. Cross-validation of the Dot Counting Test in a large sample of credible and non-credible patients referred for neuropsychological testing.
    McCaul C; Boone KB; Ermshar A; Cottingham M; Victor TL; Ziegler E; Zeller MA; Wright M
    Clin Neuropsychol; 2018 Aug; 32(6):1054-1067. PubMed ID: 29345192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross validation of the b Test in a large known groups sample.
    Roberson CJ; Boone KB; Goldberg H; Miora D; Cottingham M; Victor T; Ziegler E; Zeller M; Wright M
    Clin Neuropsychol; 2013; 27(3):495-508. PubMed ID: 23157695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wait, There's a Baby in this Bath Water! Update on Quantitative and Qualitative Cut-Offs for Rey 15-Item Recall and Recognition.
    Poynter K; Boone KB; Ermshar A; Miora D; Cottingham M; Victor TL; Ziegler E; Zeller MA; Wright M
    Arch Clin Neuropsychol; 2019 Nov; 34(8):1367-1380. PubMed ID: 30395181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-validation of RAVLT performance validity indicators and the RAVLT/RO discriminant function in a large known groups sample.
    Boone KB; Sherman D; Mishler J; Daoud G; Cottingham M; Victor TL; Ziegler E; Zeller MA; Wright M
    Clin Neuropsychol; 2022 Nov; 36(8):2342-2360. PubMed ID: 34311662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-examination of the Rey Word Recognition Test.
    Bell-Sprinkel TL; Boone KB; Miora D; Cottingham M; Victor T; Ziegler E; Zeller M; Wright M
    Clin Neuropsychol; 2013; 27(3):516-27. PubMed ID: 23216255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance and Symptom Validity Assessment in Patients with Apathy and Cognitive Impairment.
    Dandachi-FitzGerald B; Duits AA; Leentjens AFG; Verhey FRJ; Ponds RWHM
    J Int Neuropsychol Soc; 2020 Mar; 26(3):314-321. PubMed ID: 31658930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of the Modified Somatic Perception Questionnaire (MSPQ) in a large sample of credible and noncredible patients referred for neuropsychological testing.
    Balasanyan M; Boone KB; Ermshar A; Miora D; Cottingham M; Victor TL; Ziegler E; Zeller MA; Wright M
    Clin Neuropsychol; 2018 Jan; 32(1):165-182. PubMed ID: 28585455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of an attention-based performance validity test for the detection of feigned cognitive dysfunction after acquired brain injury.
    Fuermaier ABM; Tucha O; Russ D; Ehrenstein JK; Stanke M; Heindorf R; Buggenthin R; Aschenbrenner S; Koerts J; Tucha L
    J Clin Exp Neuropsychol; 2020 Apr; 42(3):285-297. PubMed ID: 32041477
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of credible patients of very low intelligence and non-credible patients on neurocognitive performance validity indicators.
    Smith K; Boone K; Victor T; Miora D; Cottingham M; Ziegler E; Zeller M; Wright M
    Clin Neuropsychol; 2014; 28(6):1048-70. PubMed ID: 24985490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Dot Counting Test adds up: Validation and response pattern analysis in a mixed clinical veteran sample.
    Soble JR; Santos OA; Bain KM; Kirton JW; Bailey KC; Critchfield EA; O'Rourke JJF; Highsmith JM; González DA
    J Clin Exp Neuropsychol; 2018 May; 40(4):317-325. PubMed ID: 28656790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity data for the b Test, Dot Counting Test, Rey-15 Item Plus Recognition, and Rey Word Recognition Test in monolingual Spanish-speakers.
    Robles L; López E; Salazar X; Boone KB; Glaser DF
    J Clin Exp Neuropsychol; 2015; 37(6):614-21. PubMed ID: 25969922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of various WAIS-IV Digit Span indices for identifying noncredible performance validity among cognitively impaired and unimpaired examinees.
    Webber TA; Soble JR
    Clin Neuropsychol; 2018 May; 32(4):657-670. PubMed ID: 29256334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of alternative dot counting test E-score cutoffs based on degree of cognitive impairment in veteran and civilian clinical samples.
    Hansen ND; Rhoads T; Jennette KJ; Reynolds TP; Ovsiew GP; Resch ZJ; Critchfield EA; Marceaux JC; O'Rourke JJF; Soble JR
    Clin Neuropsychol; 2023 Feb; 37(2):402-415. PubMed ID: 35343379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further examination of embedded performance validity indicators for the Conners' Continuous Performance Test and Brief Test of Attention in a large outpatient clinical sample.
    Sharland MJ; Waring SC; Johnson BP; Taran AM; Rusin TA; Pattock AM; Palcher JA
    Clin Neuropsychol; 2018 Jan; 32(1):98-108. PubMed ID: 28548557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the California Verbal Learning Test, Second Edition as an embedded performance validity measure among individuals with TBI and individuals with psychiatric disorders.
    Persinger VC; Whiteside DM; Bobova L; Saigal SD; Vannucci MJ; Basso MR
    Clin Neuropsychol; 2018 Aug; 32(6):1039-1053. PubMed ID: 29283307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further Validation of the Conner's Adult Attention Deficit/Hyperactivity Rating Scale Infrequency Index (CII) for Detection of Non-Credible Report of Attention Deficit/Hyperactivity Disorder Symptoms.
    Cook CM; Bolinger E; Suhr J
    Arch Clin Neuropsychol; 2016 Jun; 31(4):358-64. PubMed ID: 27193367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and specificity of the Rey Dot Counting Test in patients with suspect effort and various clinical samples.
    Boone KB; Lu P; Back C; King C; Lee A; Philpott L; Shamieh E; Warner-Chacon K
    Arch Clin Neuropsychol; 2002 Oct; 17(7):625-42. PubMed ID: 14591847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance validity of the Dot Counting Test in a dementia clinic setting.
    Monjazeb S; Crowell TA
    Appl Neuropsychol Adult; 2023 Apr; ():1-11. PubMed ID: 37119265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity rates for non-clinical, bilingual, Mexican Americans on three popular performance validity measures.
    Gasquoine PG; Weimer AA; Amador A
    Clin Neuropsychol; 2017 Apr; 31(3):587-597. PubMed ID: 28077000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation of a Cross-Domain Embedded Performance Validity Measure in Traumatic Brain Injury.
    Whiteside DM; Gaasedelen OJ; Hahn-Ketter AE; Luu H; Miller ML; Persinger V; Rice L; Basso MR
    Clin Neuropsychol; 2015; 29(6):788-803. PubMed ID: 26430920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.